CJPP welcomes unlimited fee-free open access submissions from @crkn-rcdr.bsky.social authors and provides unlimited Read Access to all @cdnsciencepub.com research. Publish with us 🍁▶️ buff.ly/2BW3zWd 🥪📃 🍎📃 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

October #EditorsChoice for CJPP by Namkoong and Minhas: A review of the common causes of acute coronary syndrome (ACS) in females, and the role of estrogen on its pathologies and risk factors Read the summary: buff.ly/kCX6zys Check out the article: buff.ly/U5NzIXq #OpenAccess #WomensHeartHealth

Final call: Applications for Editors-in-Chief close tomorrow! Submit your application now ▶️ buff.ly/dpXHw3P #AcademicLeadership #EditorInChief #CallForApplications

@physiolpharma.bsky.social is expanding its editorial board! We’re seeking clinician–researchers with expertise in clinical research to join us as Associate Editors. Details ▶️ buff.ly/4Jhh4Z9 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

Happy #OAWeek! Discover our #OpenAccess partnerships and see if your institution has an agreement with us for options with reduced fees. We're committed to advancing open access for all researchers ▶️https://buff.ly/sfa75H3

Our publisher @cdnsciencepub.com has spent 15+ years expanding open access options to make research more accessible to everyone. In our latest blog @ecolevol.bsky.social explains why there’s no one-size-fits-all approach to OA. Read more ▶️ buff.ly/utW3mcV #CSPBlog #YourResearchHome

Our publisher @cdnsciencepub.com has spent 15+ years expanding open access options to make research more accessible to everyone. In our latest blog @ecolevol.bsky.social explains why there’s no one-size-fits-all approach to OA. Read more ▶️ buff.ly/utW3mcV #CSPBlog #YourResearchHome

Our publisher @cdnsciencepub.com has spent 15+ years expanding open access options to make research more accessible to everyone. In our latest blog @ecolevol.bsky.social explains why there’s no one-size-fits-all approach to OA. Read more ▶️ buff.ly/utW3mcV #CSPBlog #YourResearchHome

Celebrate #OAWeek by exploring our #OpenAccess Glossary! Learn key terms in scholarly publishing and OA. The glossary is regularly updated with new definitions to keep you informed 🔓▶️https://buff.ly/jFtV4xA

Did you attend IACS-NAS 2025? Your research belongs in our proceedings collection! Deadline to submit is Jan 15, 2026 ▶️ buff.ly/5Q4ojDu #Physiology #Pharmacology #CardiovascularResearch #IACSNAS2025

This #OpenAccess Week, check out all the #CSPBlogs on open access! We share a whole range of perspectives on community-driven publishing and making trusted science accessible to everyone. 🔓▶️ buff.ly/TUkwWM4

We are seeing two Editors-in-Chief to guide submissions, oversee peer review, and set editorial priorities. Applications close November 1, 2025! Learn more 📥▶️https://buff.ly/dpXHw3P #EditorInChief #CallForApplications #AcademicPublishing

Reminder: Applications are open for Editors-in-Chief of CJPP! Apply by November 1, 2025📥▶️https://buff.ly/dpXHw3P #EditorInChief #CallForApplications #AcademicPublishing

Publish your next breakthrough in CJPP with no fees. Corresponding authors with @crkn-rcdr.bsky.social can submit unlimited OA manuscripts and benefit from unlimited read access. Discover how 🍁▶️ buff.ly/2BW3zWd 🥪📃 🍎📃 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

A reminder to submit your #ET19 research to our collection! Contributions from non-attendees are welcome too. Deadline: Jan 15, 2026 Details ▶️ buff.ly/qIItdkh @drkeeksphd.bsky.social

@physiolpharma.bsky.social invites applications for Editors-in-Chief to lead the journal, which publishes research in physiology, nutrition, pharmacology, and toxicology. Deadline November 1, 2025 ▶️https://buff.ly/dpXHw3P #EditorInChief #CallForApplications #AcademicPublishing

How do we safeguard academic freedom and rigorous peer review? Our CEO, @elainestott.bsky.social, and Executive Editor-in-Chief Robert Mann explain in this new #CSPBlog post🍁▶️ buff.ly/4m6ZRD5 #YourResearchHome #AcademicFreedom

NEW! We are looking for two new Editors-in-Chief. Apply before Nov 1 if you're a leader in physiology or pharmacology! Learn more and share the news▶️https://buff.ly/dpXHw3P #EditorInChief #CallForApplications

On this National Day for Truth and Reconciliation, we honor the strength and wisdom of Indigenous Peoples. Let's listen, learn, and reflect on building a more inclusive future together. #TruthAndReconciliation #IndigenousPeoples #Equity

Today, we recognize the National Day for Truth and Reconciliation by honouring the strength of Indigenous Peoples and reflecting on how we can support meaningful change. #TruthAndReconciliation #IndigenousPeoples #Equity

Sept 29 is #WorldHeartDay ❤️ The review by Namkoong and Kunal Minhas unpacks sex-specific causes of ACS in women by covering plaque rupture, SCAD, MINOCA & Takotsubo. It highlights key pathological differences and future research paths. Read it here:

Sept 29 is #WorldHeartDay❤️ Gurusamy et al highlight promising research on cardiac disease therapy: BHB ketone bodies modulate epigenetic mechanisms to enhance mitochondrial function, reduce inflammation, and support heart repair Read the paper: buff.ly/EbEVvhy

Sept 29 is #WorldHeartDay 🧠💔 Aging affects the heart, but frailty may be the real driver of late-life cardiovascular disease. Could treating frailty treat heart disease too? Read the review by Bisset and Howlett: buff.ly/gFGZlKj

Join the editorial team of @physiolpharma.bsky.social! We’re seeking Associate Editors who are active clinician–researchers in fields like oncology, renal disease, or pharmacokinetics. Learn more ▶️ buff.ly/8hc3PDY #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

Sept 29 is #WorldHeartDay ❤️ #CardiovascularDisease is the leading indirect cause of maternal morbidity and mortality, accounting for nearly 1/3 of maternal deaths during pregnancy Read the paper by Rizi et al: buff.ly/ApYogmZ #WomensHeartHealth

September 29 is #WorldHeartDay ❤️ To mark the day, #CJPPjournal is highlighting impactful research that advances our understanding of heart health and disease prevention. Stay tuned as we showcase key studies from our journal! #HeartHealth #CardiovascularResearch

Did you attend ET-19 in Charleston? Submit your research on endothelins or ERAs to our ET-19 collection. Contributions from non-attendees are welcome too! Deadline: Jan 15, 2026 Details ▶️ buff.ly/qIItdkh @drkeeksphd.bsky.social

Submissions are open: Proceedings of the IACS-NAS 2025 meeting in Las Vegas. Share your cardiovascular research in CJPP by Jan 15, 2026 ▶️ buff.ly/5Q4ojDu #Physiology #Pharmacology #CardiovascularResearch #IACSNAS2025

Join the editorial team of @physiolpharma.bsky.social! We’re seeking Associate Editors who are active clinician–researchers in fields like oncology, renal disease, or pharmacokinetics. Learn more ▶️ buff.ly/4Jhh4Z9 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

Why become a peer reviewer? Peer review lets researchers give back while sharpening their own skills. Learn how to get involved and support strong Canadian research 📖▶️ buff.ly/QmPBqlJ #PeerReviewWeek #PRW2025

We're excited to welcome the Journal of Psychiatry & Neuroscience (JPN) to our portfolio! JPN shares new research at the intersection of brain science and mental health. Learn more ➡️ buff.ly/XV7IaaO Give them a follow: @jpnjournal.bsky.social #AcademicSky #PsychSciSky #Neuroscience #Neuroskyence

Unlimited open access publishing in CJPP—no fees for corresponding authors at @crkn-rcdr.bsky.social affiliated universities. Plus gain unlimited Read Access to @cdnsciencepub.com journals! Publish with us 🍁▶️ buff.ly/2BW3zWd

@physiolpharma.bsky.social is expanding its editorial board! We’re seeking clinician–researchers with expertise in clinical research to join us as Associate Editors. Details ▶️ buff.ly/4Jhh4Z9 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

📣New discovery in calcium signaling Dai et al identified MTMR7 as a novel STIM1-binding protein, establishing a connection between phosphoinositide metabolism and Ca2+ signaling. This could help target disorders tied to calcium imbalance. 🔗https://buff.ly/WfpSMwp #OpenAccess

CJPP welcomes unlimited fee-free open access submissions from @crkn-rcdr.bsky.social authors and provides unlimited Read Access to all research. Publish with us 🍁▶️ buff.ly/2BW3zWd 🥪📃 🍎📃

📣New discovery in calcium signaling Dai et al identified MTMR7 as a novel STIM1-binding protein, establishing a connection between phosphoinositide metabolism and Ca2+ signaling. This could help target disorders tied to calcium imbalance. Read it here: buff.ly/IL9Pcm0 #OpenAccess

We are hitting the road in 2025! Explore where our team will be and how you can engage with us at this year’s biggest scientific conferences ▶️ buff.ly/OAznT5J #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

We’re here to support Canadian researchers at every step of the publishing journey. Enter a draw to win an open access waiver with no APCs or fees. Learn more ▶️ buff.ly/N6VNZX7 #YourResearchHome

Whether you focus on EDIA, sustainability, or academic freedom, your work matters. Enter our draw for a chance to win a waiver and publish #OpenAccess with no APCs. #YourResearchHome ▶️ buff.ly/N6VNZX7

📣Announcing July CJPP's #EditorsChoice! Nampt: a new therapeutic target for modulating NAD+ levels in metabolic, cardiovascular, and neurodegenerative diseases | Manickam et al 📖https://buff.ly/boo7ArZ 🔗https://buff.ly/TkSwoCU #OpenAccess #Nampt #NAD+ #diabetes #CVD #NeurodegenerativeDisease

📣The June CJPP #EditorsChoice is by Camenzuli et al: Effects of acute aerobic exercise on skeletal muscle and liver glucose metabolism in male rodents with type 1 diabetes 📖https://buff.ly/TnMKF6N 🔗https://buff.ly/991yVWq #Type1DiabetesMellitus #OpenAccess @westernu.ca

CJPP welcomes unlimited fee-free open access submissions from @crkn-rcdr.bsky.social authors and provides unlimited Read Access to all @cdnsciencepub.com research. Publish with us 🍁▶️ buff.ly/2BW3zWd 🥪📃 🍎📃 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

NEW: We're #hiring for a Research Integrity Specialist! You'll help manage ethics cases, support policy development, and foster an integrity-focused culture across our journals. Details and application 💼▶️ buff.ly/z87Bdi1 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

We believe in supporting research that drives positive change. Enter a draw to win a waiver for open access publishing with no APCs or fees. #YourResearchHome ➡️ buff.ly/N6VNZX7

Join the editorial team of @physiolpharma.bsky.social! We’re seeking Associate Editors who are active clinician–researchers in fields like oncology, renal disease, or pharmacokinetics. Learn more ▶️ buff.ly/4Jhh4Z9 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

Missed the webinar? The recording is now available! Learn how to plan your publication, select the right journal, write clear titles and abstracts, and navigate Open Access publishing. 📽️▶️ buff.ly/iYbfBsA #ResearchSkills #OpenAccess #ECRs #AcademicWriting

We're #hiring for a Research Integrity Specialist to support research quality and publishing ethics across our journals. Apply now 💼▶️ buff.ly/z87Bdi1 #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

NEW! We’re pleased to welcome the Journal of Psychiatry and Neuroscience (JPN) to our journal portfolio effective Sept. 2. JPN publishes research on the neural mechanisms of psychiatric disorders and will join our portfolio this fall. Details ▶️ buff.ly/WzUX5xq #AcademicSky #SciComm 🧪 #PHDSky

⏰ Last call! Join us today for a free webinar on how to plan your publication, choose the right journal, and write effective titles and abstracts. 📅 June 25 | 1 p.m. GMT 🎓 Ideal for early-career researchers ▶️ buff.ly/YvvM2GM #AcademicSky #SciComm 🧪 #AcWri #PHDSky #ScholComms #OpenScience #SciPol

@physiolpharma.bsky.social is expanding its editorial board! We’re seeking clinician–researchers with expertise in clinical research to join us as Associate Editors. Details ▶️ buff.ly/4Jhh4Z9